Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 8:53 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 505–528 of 1,551 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Ulcerative Clear all

Conditions: Diabetic Foot Ulcers
Interventions: Regranex®, Hydrogel; Drug
Lead sponsor: Southern California Institute for Research and Education; Other
Eligibility: 21 Years to 85 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 2
States / cities: Long Beach, California • Los Angeles, California

Conditions: Diabetic Foot Ulcer
Interventions: Removable cam walker boot, Counseling; Device · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Not listed
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Chicago, Illinois • Hines, Illinois

Conditions: Diabetic Foot Ulcers
Interventions: Prevention Diabetic Foot Ulcer; Device
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 750 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2002
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Venous Leg Ulcer, Chronic Venous Insufficiency, Venous Stasis Ulcer, Venous Ulcer, Venous Insufficiency
Interventions: Dual Action Pneumatic Compression; Device
Lead sponsor: Tactile Medical; Industry
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 6
States / cities: San Francisco, California • Miami, Florida • Boston, Massachusetts + 2 more

Conditions: Ulcerative Colitis, Crohn Disease, Irritable Bowel, Crohns Disease Aggravated, Crohn Disease in Remission
Interventions: Not listed
Lead sponsor: Viome; Industry
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Bothell, Washington

Conditions: Venous Insufficiency
Interventions: Compression stocking 15-20mmHg, Compression stocking 20-30mmHg; Device
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Richmond Heights, Ohio

Conditions: Chronic Diabetic Foot Ulcers, Diabetic Neuropathic Ulcers, Non Healing Wound
Interventions: Timolol, Non biologically active gel; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Ulcerative Colitis
Interventions: Tauroursoursodeoxycholic acid, brand name Tudcabil; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 65 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 3
States / cities: Creve Coeur, Missouri • St Louis, Missouri

Conditions: Ulcerative Colitis, Ulcerative Colitis Chronic
Interventions: Mirikizumab; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 172 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 49
States / cities: Litchfield Park, Arizona • Sun City, Arizona • Lancaster, California + 41 more

Conditions: Venous Leg Ulcer
Interventions: Varithena; Drug
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 76 participants
Timeline: 2017 – 2020
U.S. locations: 13
States / cities: Palo Alto, California • Sacramento, California • Darien, Connecticut + 10 more

Conditions: Ulcerative Colitis
Interventions: Lutikizumab, Adalimumab; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years and older
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 48
States / cities: Chula Vista, California • Coronado, California • Huntington Beach, California + 37 more

Conditions: Aortic Dissection, Aortic Aneurysm, Intramural Hematoma, Penetrating Aortic Ulcer
Interventions: NEXUS Aortic Stent Graft System; Device
Lead sponsor: Endospan Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2029
U.S. locations: 31
States / cities: Birmingham, Alabama • La Jolla, California • Sacramento, California + 27 more

Conditions: Inflammation, Burns, Ulcers
Interventions: Mepilex Border Ag; Device
Lead sponsor: Molnlycke Health Care AB; Industry
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 3
States / cities: Momtgomery, Alabama • Iowa City, Iowa • The Bronx, New York

Conditions: Foot Ulcer, Diabetic, Diabetes Complications
Interventions: MRE0094; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 322 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 63
States / cities: Montgomery, Alabama • Bullhead City, Arizona • Phoenix, Arizona + 56 more

Conditions: Ulcerative Colitis
Interventions: Telotristat Etiprate, Placebo; Drug
Lead sponsor: Lexicon Pharmaceuticals; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 11
States / cities: Little Rock, Arkansas • Anaheim, California • Santa Monica, California + 8 more

Conditions: Ulcerative Colitis
Interventions: Kyo-Dophilus, placebo; Dietary Supplement
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 1
States / cities: Orange, California

Conditions: Infected Corneal Ulcers, Bacterial Keratitis, Corneal Ulcer, Childhood Blindness
Interventions: Povidone-Iodine; Drug
Lead sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Other
Eligibility: 1 Month and older
Enrollment: 172 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2006
U.S. locations: 1
States / cities: Torrance, California

Conditions: Crohn's Disease, Ulcerative Colitis
Interventions: Not listed
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Ulcer, Wounds
Interventions: Active Leptospermum Honey (Medihoney), Collagenase; Device · Drug
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Diabetic Foot Ulcer
Interventions: vancomycin-tobramycin-itraconazole; Drug
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Diabetic Foot Ulcer
Interventions: SECONDARY dressing gauze and tape, debridement, irrigation, Dermagraft, Oasis; Device · Procedure
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 85 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Pyoderma Gangrenosum
Interventions: Dehydrated human amnion/chorion membrane; Biological
Lead sponsor: Louisiana State University Health Sciences Center in New Orleans; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 3
States / cities: Metairie, Louisiana • New Orleans, Louisiana

Conditions: Esophagitis, Gastroesophageal Reflux, Stomach Ulcer, Duodenal Ulcer
Interventions: S-Tenatoprazole-Na (STU-Na); Drug
Lead sponsor: STEBA France; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Pyoderma Gangrenosum, Skin Diseases, Wound Heal, Pyoderma, Skin Ulcer
Interventions: Baricitinib; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Portland, Oregon

Search by objective public record fields.

Evaluation of Windowed Casts With and Without Regranex® Gel for Healing Diabetic Neuropathic Ulcers

Orthotic Treatment of Diabetic Foot Ulcers

A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk

Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers (VLUs)

Microbial and Human Determinants of the Onset of IBD Flares

Compliance of Compression Therapy in Healed Venous Ulcerations

Beta Adrenergic Antagonist for the Healing of Chronic DFU

TUDCA as a Therapy for Ulcerative Colitis (UC)

A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis

Effect of VarIthena on Wound Healing in Venous Leg Ulcers (VLU)

A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis

NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness

Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing

Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers

A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative Colitis

Effects of Probiotics in Patients With Ulcerative Colitis

A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers

Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use

MEDIHONEY® Gel Versus Collagenase for Wound Debridement

Evaluating the Healing of Diabetic Foot Ulcers With Compounded Anti-Infective Irrigation Therapy

VA MERIT: A Comparative Efficacy Study: Treatment of Non-Healing Diabetic

A Novel Therapeutic Treatment of Pyoderma Gangrenosum

Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers

Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG)